Tigress Financial analyst issues BUY recommendation for TSLA on October 8, 2026 08:19PM ET. The previous analyst recommendation was Buy.TSLA was trading at $375 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst recommendations are : 34 - Buy, 33 - Hold, 15 - Sell recommendations .Historical Analyst RecommendationsLatest 10 recommendationsReport DateAnalyst...
Barclays analyst issues OVERWEIGHT recommendation for PLTR on October 8, 2026 08:24PM ET. PLTR was trading...
Barclays analyst issues OVERWEIGHT recommendation for RTX on October 8, 2026 08:25PM ET. The previous analyst...
Barclays analyst issues OVERWEIGHT recommendation for BA on October 8, 2026 08:25PM ET. The previous analyst...
Following are the Top 5 companies based on their one-day percentage change within the 'Welcome to...
Jeff Cantwell from Seaport Global issued a price target of $180.00 for SHOP on 2026-10-08 13:59:02.The adjusted price target was set to $180.00.At the time of the announcement, SHOP was...
from Jefferies issued a price target of $54.00 for U on 2026-10-08 12:40:45.The adjusted price target was set to $54.00.At the time of the announcement, U was trading at $46.65.The...
from UBS issued a price target of $37.00 for XP on 2026-10-08 11:57:02.The adjusted price target was set to $37.00.At the time of the announcement, XP was trading at $30.445.The...
from UBS issued a price target of $88.00 for FCX on 2026-10-08 11:55:35.The adjusted price target was set to $88.00.At the time of the announcement, FCX was trading at $71.865.The...
Carter Gould from Cantor Fitzgerald issued a price target of $28.00 for PFE on 2026-10-08 11:17:00.The adjusted price target was set to $28.00.At the time of the announcement, PFE was...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
Micron Technology, Inc. (NASDAQ: MU) is making headlines as its shares begin to recover, buoyed by revised earnings estimates that reflect a promising outlook for the semiconductor giant. Known for...
Tesla Inc. is navigating a complex landscape as it confronts both opportunities and challenges. While recent financial performance has raised eyebrows, especially in light of cash burn and earnings misses,...
In a significant shift for the AI sector, stocks of leading companies such as Nvidia, Oracle, and CoreWeave experienced a notable decline after revelations from OpenAI regarding its revenue figures....
Broadcom is stepping into the financial spotlight, reportedly arranging over $50 billion in financing aimed at developing custom artificial intelligence (AI) chips in collaboration with OpenAI. This move highlights the...
In a notable development, the U.S. Labor Department has suspended Microsoft from the federal program designed to assist foreign workers in maintaining their employment status in the United States. This...
